Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr
Chemical

Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr

The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.

  • By ICN Bureau | July 28, 2021

Aarti Drugs Ltd has reported total income of Rs.581.57 crores during the period ended June 30, 2021 as compared to Rs.502.72 crores during the period ended March 31, 2021.

The company reported total income Rs.545.93 crores during the period ended June 30, 2020.

Aarti Drugs has posted net profit of Rs.48.81 crores for the period ended June 30, 2021 as against net profit of Rs.51.65 crores for the period ended March 31, 2021.

The company posted net profit of Rs.85.45 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.5.25 for the period ended June 30, 2021 as compared to Rs.9.17 for the period ended June 30, 2020.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization